Skip to main content
Premium Trial:

Request an Annual Quote

Bringing Science Back

Adaptive Complexity links out to a new report from the Woodrow Wilson International Center for Scholars, which has some strong recommendations for the next president when it comes to the role of science advisor. One is to restore the Director of the Office of Science and Technology Policy to status of "Assistant to the President." Basically, to make science and technology a priority, "it is critical for the President to have a close advisor to coordinate and prioritize the budget requests from all of the federal science agencies, to communicate on science and technology issues with Congress, the public, and academic and industry representatives, and to provide the President with sound technical advice on science policy," Michael White writes.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.